Pemetrexed monochemotherapy in patients with locally advanced or metastatic non small cell lung cancer. A pilot study to define the best dosing schedule for a planned phase II randomized trial
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 06 Nov 2008 Status changed from active, no longer recruiting to completed, based on information from ClinicalTrials.gov.
- 26 Apr 2008 Status changed from recruiting to in progress.